改变世界:5年心脏外科跨社会联盟 (CSIA)
R M Bolman1, P Zilla2, F Beyersdorf3
1Division of Cardio-Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minn.
The Journal of thoracic and cardiovascular surgery
|June 12, 2024
概括
心脏外科协会联盟 (CSIA) 在莫桑比克和卢旺达建立了试点项目,以建立可持续的心脏外科能力. 这些举措改善了低收入国家的患者护理和政府支持.
科学领域:
- 全球健康 全球健康
- 心胸外科手术 心胸外科手术
- 国际发展国际发展
背景情况:
- 发展中国家心脏外科手术的巨大未满足需求.
- 全球卫生领导人强调的获得护理的不平等.
- 形成心脏外科跨社会联盟 (CSIA),以解决这一差距.
研究的目的:
- 在低收入国家倡导和加强可持续的,本地心脏手术能力.
- 在发展中国家建立心脏手术试点项目.
- 评估CSIA倡议对当地医疗保健系统的影响.
主要方法:
- 全球需求评估确定风湿性心脏病作为主要病理.
- 根据提案和评估,选择莫桑比克和卢旺达作为试点地点.
- 实施指导和培训协议,包括虚拟和现场支持.
- 与非政府组织和学术机构建立伙伴关系,以转移知识.
主要成果:
- 在莫桑比克和卢旺达成功建立了心脏手术项目.
- 增加了手术病例数量,并改善了政府在试点地点的承诺.
- 升级基础设施,行业捐款,以及获得全球资助的进展.
- 通过CSIA"批准印章"证明了可持续性和能力建设.
结论:
- 在低收入国家,CSIA模型有效地促进了可持续的心脏手术能力.
- 国际合作和指导对于改善获得心脏护理的机会至关重要.
- "批准印章"机制可以指导全球成功计划的进一步扩张.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
712
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
